Shares of Viking Therapeutics (VKTX 2.88%), a mid-cap biotech, are down by 34% this year. This poor performance may suggest that recent company-specific developments have rendered the stock less attractive or that it is being affected by broader market issues. The latter is true, at least to some extent, but Viking Therapeutics’ thesis has not

Looking for a high-yield opportunity after a big pullback? Discover why this familiar name might be worth another look in June 2025. Shares of freight service veteran UPS (UPS 1.38%) are diving these days. The stock is down 24% in the last six months, building on a longer downturn that started in the inflation panic

What caused the clashes?published at 08:22 British Summer Time 08:22 BST Image source, AFP via Getty Images Clashes were seen in the Los Angeles area on Friday after Immigration Customs Enforcement (ICE) immigration raids were carried out across the city. The BBC’s US partner, CBS, reports that operations took place in the city, in the